Cargando…

Impact of Intercurrent Introduction of Steroids on Clinical Outcomes in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients under Immune-Checkpoint Inhibitors (ICI)

SIMPLE SUMMARY: Recently, the introduction of immunotherapy radically changed the therapeutic algorithm of non-small-cell lung cancer as an upfront or secondary strategy. Unfortunately, the small amount of patient benefits from immune-checkpoint inhibitors (ICI) and the prognostic role of concomitan...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Giglio, Andrea, Mezquita, Laura, Auclin, Edouard, Blanc-Durand, Félix, Riudavets, Mariona, Caramella, Caroline, Martinez, Gala, Benitez, Jose Carlos, Martín-Romano, Patricia, El-Amarti, Lamiae, Hendriks, Lizza, Ferrara, Roberto, Naltet, Charles, Lavaud, Pernelle, Gazzah, Anas, Adam, Julien, Planchard, David, Chaput, Nathalie, Besse, Benjamin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599488/ https://www.ncbi.nlm.nih.gov/pubmed/33007977 http://dx.doi.org/10.3390/cancers12102827

Ejemplares similares

Chronic Plasma Exposure to Kinase Inhibitors in Patients with Oncogene-Addicted Non-Small Cell Lung Cancer
por: Geraud, Arthur, et al.
Publicado: (2020)

Meningeal “Lazarus Response” to Lorlatinib in a ROS1-Positive NSCLC Patient Progressing to Entrectinib
por: Facchinetti, Francesco, et al.
Publicado: (2021)

Unexpected Cardiotoxicity in Patients With HER2-Mutant NSCLC Treated With Trastuzumab Deruxtecan: A Case Report
por: Riudavets, Mariona, et al.
Publicado: (2022)

Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
por: Oulhen, Marianne, et al.
Publicado: (2021)

Radon and Lung Cancer: Current Trends and Future Perspectives
por: Riudavets, Mariona, et al.
Publicado: (2022)

Differentiation of COVID-19 Pneumonitis and ICI Induced Pneumonitis
por: Dumoulin, Daphne W., et al.
Publicado: (2020)

Cerebral Meningitis (Intercurrent)
por: Hay, Walter
Publicado: (1875)

Intercurrent Remedies for Chronic Diseases
Publicado: (1889)

CD8(+)PD-1(+) to CD4(+)PD-1(+) ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers
por: Duchemann, Boris, et al.
Publicado: (2022)

Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer
por: Park, Wungki, et al.
Publicado: (2019)

Comment on Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 2021, 13, 1176
por: Auclin, Edouard, et al.
Publicado: (2021)

Intercurrent events in clinical research: the norm, not the exception
por: Rojas-Saunero, L. Paloma, et al.
Publicado: (2022)

Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy
por: Recondo, Gonzalo, et al.
Publicado: (2020)

Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer
por: Schernberg, Antoine, et al.
Publicado: (2018)

Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung Cancer
por: Duchemann, Boris, et al.
Publicado: (2020)

Immunity against Helminths: Interactions with the Host and the Intercurrent Infections
por: Moreau, Emmanuelle, et al.
Publicado: (2010)

Rethinking intercurrent events in defining estimands for tuberculosis trials
por: Pham, Tra My, et al.
Publicado: (2022)

Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma
por: Parent, Pauline, et al.
Publicado: (2023)

Immune checkpoint inhibitors in elderly patients treated for a lung cancer: a narrative review
por: Naltet, Charles, et al.
Publicado: (2021)

Real-World Utility of an Amplicon-Based Next-Generation Sequencing Liquid Biopsy for Broad Molecular Profiling in Patients With Advanced Non–Small-Cell Lung Cancer
por: Remon, Jordi, et al.
Publicado: (2019)

The Physical Examination of the Chest in Pulmonary Consumption and Its Intercurrent Diseases
Publicado: (1861)

Retrospective study on intercurrent pancreatitis with Babesia gibsoni infection in dogs
por: MASUDA, Misa, et al.
Publicado: (2019)

Diathesis and Cachexiæ during Intercurrent Attacks—The Importance of Their Recognition and Treatment
por: Winston, Geo. H.
Publicado: (1890)

Translating questions to estimands in randomized clinical trials with intercurrent events
por: Stensrud, Mats J., et al.
Publicado: (2022)

Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer()
por: Levy, Antonin, et al.
Publicado: (2023)

Strategies to overcome trastuzumab resistance in HER2-overexpressing breast cancers: focus on new data from clinical trials
por: Lavaud, Pernelle, et al.
Publicado: (2014)

Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
por: De Giglio, Andrea, et al.
Publicado: (2022)

Integrin-α(V)-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade
por: Malenica, Ines, et al.
Publicado: (2021)

Intercurrent and opportunistic infections in patients treated with biological agents: study hypothesis
por: Popescu, Ramona Ștefania, et al.
Publicado: (2014)

Is there any opportunity for immune checkpoint inhibitor therapy in non-small cell lung cancer patients with brain metastases?
por: Hendriks, Lizza E. L., et al.
Publicado: (2021)

Targeting HER2 in non-small-cell lung cancer (NSCLC): a glimpse of hope? An updated review on therapeutic strategies in NSCLC harbouring HER2 alterations
por: Riudavets, M., et al.
Publicado: (2021)

Impact of intercurrent illness on calcium homeostasis in children with hypoparathyroidism: a case series
por: Chinoy, A, et al.
Publicado: (2017)

ICIS05 CONFERENCE
por: Lau, C, et al.
Publicado: (02/1)

The Icy Realm of the Rime
por: Potter, Polyxeni
Publicado: (2011)

Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI Score
por: Pierro, Monica, et al.
Publicado: (2022)

Comorbidities, clinical intercurrences, and factors associated with mortality in elderly patients admitted for a hip fracture()
por: Edelmuth, Stephanie Victoria Camargo Leão, et al.
Publicado: (2018)

Impact of intercurrent respiratory infections on lung health in infants born <29 weeks with bronchopulmonary dysplasia
por: Taylor, J B, et al.
Publicado: (2013)

Handling death as an intercurrent event in time to recovery analysis in COVID-19 treatment clinical trials
por: Li, Hong, et al.
Publicado: (2022)

Enceladus and the icy moons of Saturn
por: Schenk, Paul M, et al.
Publicado: (2018)

Ici, priorité ... aux piétons !
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_ikl4i7v5r6tucn30oo2p993tfo